Acutaas Chemicals Limited Share Price & Analysis
₹3,677▲ +0.57%Updated 21 Jul 2026, 05:01 pm IST
LTP
₹3,677
+0.57%
Open
₹—
High
₹3,700
Low
₹3,649
Close
₹3,677
52W High
₹3,740
52W Low
₹1,125
Volume
180K
Lot Size
1
Sector
Healthcare
Market Cap
₹30K Cr
Face Value
₹5
Large CapNIFTY 500
Price Chart
Fundamentals
P/E
83.2
Sector P/E
54.4
P/B
15.04
EPS
₹35.02
ROE
24%
ROCE
31.6%
D/E Ratio
0.02
Div Yield
0.04%
Book Value
₹202
+
Strengths
- ✓Excellent return on equity (ROE 24%)
- ✓Efficient capital deployment (ROCE 31.6%)
- ✓Virtually debt-free
−
Concerns
- ✗Premium to sector peers (P/E 83.2x vs industry 54.4x)
- ✗High premium to book value (P/B 15x)
- ✗Trading near 52-week high (₹3,740)
Peer Comparison
| Company | CMP | Mkt Cap | P/E | P/B | ROE % | ROCE % | D/E |
|---|---|---|---|---|---|---|---|
| SUNPHARMA Sun Pharmaceutical Industries Limited | ₹1,944 | ₹4.6L Cr | 37.3 | 5.59 | 16 | 20.5 | 0.07 |
| DIVISLAB Divi's Laboratories Limited | ₹7,388 | ₹1.9L Cr | 73.4 | 11.71 | 16.5 | 22 | 0.01 |
| TORNTPHARM Torrent Pharmaceuticals Limited | ₹5,040 | ₹1.6L Cr | 73.6 | 20.32 | 27.4 | 15.2 | 0.33 |
| APOLLOHOSP Apollo Hospitals Enterprise Limited | ₹8,939 | ₹1.3L Cr | 64.9 | 13.56 | 22.1 | 17.9 | 0.88 |
| CIPLA Cipla Limited | ₹1,416 | ₹1.1L Cr | 30.1 | 3.32 | 11.6 | 15.5 | 0.01 |
| ZYDUSLIFE Zydus Lifesciences Limited | ₹1,123 | ₹1.1L Cr | 21 | 4.17 | 21.2 | 21.1 | 0.38 |
| LUPIN Lupin Limited | ₹2,405 | ₹1.1L Cr | 19.6 | 4.9 | 28.7 | 29.9 | 0.32 |
Showing 7 peers in the same sector · Sorted by market cap
Shareholding Pattern
ACUTAAS · as of Mar 2026
Promoters35.96%
FII16.48%▲0.96
DII18.31%▼1.92
Public29.22%▲0.95
Govt0.01%
| Category | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoters | 39.91% | 39.91% | 35.98% | 35.97% | 35.96% | 35.96% |
| FII | 11.66% | 8.98% | 12.93% | 13.87% | 15.52% | 16.48% |
| DII | 7.58% | 6.80% | 14.81% | 19.93% | 20.23% | 18.31% |
| Public | 40.85% | 44.31% | 36.28% | 30.24% | 28.27% | 29.22% |
| Govt | — | — | — | — | 0.01% | 0.01% |
Corporate Events
To consider and approve the financial results for the period ended Jun 30, 2026
Results23 Jul 2026
Dividend - Rs 1.50 Per Share
Dividend17 Sept 2025
Face Value Split (Sub-Division) - From Rs 10/- Per Share To Rs 5/- Per Share
Split24 Apr 2025
Dividend - Rs 3 Per Share
Dividend12 Sept 2024
Annual General Meeting
AGM12 Sept 2024
Annual General Meeting
AGM17 Sept 2023
Dividend - Rs 3 Per Share
Dividend17 Sept 2023
Financials
Quarterly Results
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹433 Cr ▲10.2% | ₹393 Cr ▲28.4% | ₹306 Cr ▲47.8% | ₹207 Cr ▼32.8% | ₹308 Cr ▲12.0% | ₹275 Cr ▲11.3% | ₹247 Cr ▲39.5% | ₹177 Cr |
| Op. Profit | ₹184 Cr ▲21.9% | ₹151 Cr ▲58.9% | ₹95 Cr ▲86.3% | ₹51 Cr ▼40.0% | ₹85 Cr ▲23.2% | ₹69 Cr ▲40.8% | ₹49 Cr ▲63.3% | ₹30 Cr |
| OPM | 42.0% ▲10.5% | 38.0% ▲22.6% | 31.0% ▲24.0% | 25.0% ▼10.7% | 28.0% ▲12.0% | 25.0% ▲25.0% | 20.0% ▲17.6% | 17.0% |
| Net Profit | ₹134 Cr ▲26.4% | ₹106 Cr ▲47.2% | ₹72 Cr ▲63.6% | ₹44 Cr ▼30.2% | ₹63 Cr ▲40.0% | ₹45 Cr ▲18.4% | ₹38 Cr ▲153.3% | ₹15 Cr |
| EPS (₹) | 16.09 ▲22.0% | 13.19 ▲49.5% | 8.82 ▲63.0% | 5.41 ▼29.1% | 7.63 ▲39.0% | 5.49 ▲20.4% | 4.56 ▲166.7% | 1.71 |
Values in ₹ Cr · Source: Screener.in
Annual Profit & Loss
| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ₹1.3K Cr ▲33.0% | ₹1.0K Cr ▲40.4% | ₹717 Cr ▲16.2% | ₹617 Cr ▲18.7% | ₹520 Cr ▲52.5% | ₹341 Cr ▲42.1% | ₹240 Cr ▲0.4% | ₹239 Cr ▲27.1% | ₹188 Cr ▲17.5% | ₹160 Cr |
| Expenses | ₹859 Cr ▲10.8% | ₹775 Cr ▲31.6% | ₹589 Cr ▲19.5% | ₹493 Cr ▲18.8% | ₹415 Cr ▲59.6% | ₹260 Cr ▲31.3% | ₹198 Cr ▲1.0% | ₹196 Cr ▲24.8% | ₹157 Cr ▲14.6% | ₹137 Cr |
| Op. Profit | ₹480 Cr ▲106.9% | ₹232 Cr ▲81.3% | ₹128 Cr ▲4.1% | ₹123 Cr ▲17.1% | ₹105 Cr ▲31.3% | ₹80 Cr ▲90.5% | ₹42 Cr ▲0.0% | ₹42 Cr ▲35.5% | ₹31 Cr ▲34.8% | ₹23 Cr |
| OPM | 36.0% ▲56.5% | 23.0% ▲27.8% | 18.0% ▼10.0% | 20.0% ▲0.0% | 20.0% ▼16.7% | 24.0% ▲41.2% | 17.0% ▼5.6% | 18.0% ▲12.5% | 16.0% ▲14.3% | 14.0% |
| Other Income | ₹42 Cr ▲147.1% | ₹17 Cr ▲168.0% | ₹-25 Cr ▼725.0% | ₹4 Cr ▲33.3% | ₹3 Cr ▲200.0% | ₹1 Cr ▼50.0% | ₹2 Cr | ₹0 Cr ▼100.0% | ₹3 Cr | ₹0 Cr |
| Interest | ₹3 Cr ▼50.0% | ₹6 Cr ▲0.0% | ₹6 Cr ▲200.0% | ₹2 Cr ▼66.7% | ₹6 Cr ▲0.0% | ₹6 Cr ▲0.0% | ₹6 Cr ▲20.0% | ₹5 Cr ▲66.7% | ₹3 Cr ▲0.0% | ₹3 Cr |
| Depreciation | ₹36 Cr ▲33.3% | ₹27 Cr ▲68.8% | ₹16 Cr ▲33.3% | ₹12 Cr ▲20.0% | ₹10 Cr ▲150.0% | ₹4 Cr ▲0.0% | ₹4 Cr ▲33.3% | ₹3 Cr ▲50.0% | ₹2 Cr ▲100.0% | ₹1 Cr |
| PBT | ₹483 Cr ▲123.6% | ₹216 Cr ▲163.4% | ₹82 Cr ▼26.8% | ₹112 Cr ▲23.1% | ₹91 Cr ▲26.4% | ₹72 Cr ▲105.7% | ₹35 Cr ▲0.0% | ₹35 Cr ▲25.0% | ₹28 Cr ▲47.4% | ₹19 Cr |
| Tax % | 26.0% ▲0.0% | 26.0% ▼36.6% | 41.0% ▲57.7% | 26.0% ▲23.8% | 21.0% ▼16.0% | 25.0% ▲19.0% | 21.0% ▼38.2% | 34.0% ▼2.9% | 35.0% ▲0.0% | 35.0% |
| Net Profit | ₹356 Cr ▲122.5% | ₹160 Cr ▲226.5% | ₹49 Cr ▼41.0% | ₹83 Cr ▲15.3% | ₹72 Cr ▲33.3% | ₹54 Cr ▲100.0% | ₹27 Cr ▲17.4% | ₹23 Cr ▲27.8% | ₹18 Cr ▲50.0% | ₹12 Cr |
| EPS (₹) | 43.51 ▲124.5% | 19.38 ▲234.1% | 5.8 ▼49.3% | 11.43 ▲15.8% | 9.87 ▲15.2% | 8.57 ▼34.5% | 13.08 ▲17.8% | 11.1 ▼82.0% | 61.67 ▲53.5% | 40.17 |
| Div Payout | 6.0% ▼25.0% | 8.0% ▼69.2% | 26.0% ▲100.0% | 13.0% ▼13.3% | 15.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Values in ₹ Cr · Source: Screener.in
Balance Sheet
| Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Liabilities | ||||||||||
| Equity Capital | ₹41 Cr ▲0.0% | ₹41 Cr ▲10.8% | ₹37 Cr ▲2.8% | ₹36 Cr ▲0.0% | ₹36 Cr ▲12.5% | ₹32 Cr ▲220.0% | ₹10 Cr ▲0.0% | ₹10 Cr ▲400.0% | ₹2 Cr ▲0.0% | ₹2 Cr |
| Reserves | ₹1.6K Cr ▲27.1% | ₹1.3K Cr ▲99.2% | ₹637 Cr ▲14.2% | ₹558 Cr ▲14.8% | ₹486 Cr ▲260.0% | ₹135 Cr ▲33.7% | ₹101 Cr ▲40.3% | ₹72 Cr ▲28.6% | ₹56 Cr ▲51.4% | ₹37 Cr |
| Borrowings | ₹36 Cr ▲176.9% | ₹13 Cr ▼94.0% | ₹217 Cr ▲5325.0% | ₹4 Cr ▲300.0% | ₹1 Cr ▼99.3% | ₹137 Cr ▲132.2% | ₹59 Cr ▲9.3% | ₹54 Cr ▲22.7% | ₹44 Cr ▲63.0% | ₹27 Cr |
| Other Liabilities | ₹295 Cr ▲30.0% | ₹227 Cr ▲10.7% | ₹205 Cr ▲21.3% | ₹169 Cr ▲24.3% | ₹136 Cr ▲23.6% | ₹110 Cr ▲80.3% | ₹61 Cr ▼20.8% | ₹77 Cr ▲42.6% | ₹54 Cr ▲25.6% | ₹43 Cr |
| Total Liabilities | ₹2.0K Cr ▲28.1% | ₹1.5K Cr ▲41.3% | ₹1.1K Cr ▲42.9% | ₹767 Cr ▲16.4% | ₹659 Cr ▲59.6% | ₹413 Cr ▲78.0% | ₹232 Cr ▲8.9% | ₹213 Cr ▲37.4% | ₹155 Cr ▲42.2% | ₹109 Cr |
| Assets | ||||||||||
| Fixed Assets | ₹745 Cr ▲30.7% | ₹570 Cr ▲33.5% | ₹427 Cr ▲64.9% | ₹259 Cr ▲26.3% | ₹205 Cr ▲10.2% | ₹186 Cr ▲118.8% | ₹85 Cr ▲7.6% | ₹79 Cr ▲146.9% | ₹32 Cr ▲14.3% | ₹28 Cr |
| CWIP | ₹332 Cr ▲155.4% | ₹130 Cr ▲4.0% | ₹125 Cr ▲316.7% | ₹30 Cr ▲900.0% | ₹3 Cr | ₹0 Cr ▼100.0% | ₹12 Cr ▲500.0% | ₹2 Cr ▼93.3% | ₹30 Cr ▲172.7% | ₹11 Cr |
| Investments | ₹0 Cr | ₹0 Cr | ₹0 Cr ▼100.0% | ₹2 Cr ▲0.0% | ₹2 Cr ▲100.0% | ₹1 Cr ▼50.0% | ₹2 Cr ▲0.0% | ₹2 Cr ▼33.3% | ₹3 Cr ▲200.0% | ₹1 Cr |
| Other Assets | ₹907 Cr ▲7.0% | ₹848 Cr ▲56.2% | ₹543 Cr ▲13.8% | ₹477 Cr ▲6.0% | ₹450 Cr ▲100.0% | ₹225 Cr ▲69.2% | ₹133 Cr ▲1.5% | ₹131 Cr ▲44.0% | ₹91 Cr ▲33.8% | ₹68 Cr |
| Total Assets | ₹2.0K Cr ▲28.1% | ₹1.5K Cr ▲41.3% | ₹1.1K Cr ▲42.9% | ₹767 Cr ▲16.4% | ₹659 Cr ▲59.6% | ₹413 Cr ▲78.0% | ₹232 Cr ▲8.9% | ₹213 Cr ▲37.4% | ₹155 Cr ▲42.2% | ₹109 Cr |
Values in ₹ Cr · Source: Screener.in
Cash Flow Statement
| Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating CF | ₹292 Cr ▲147.5% | ₹118 Cr ▼5.6% | ₹125 Cr ▲89.4% | ₹66 Cr ▲650.0% | ₹-12 Cr ▼142.9% | ₹28 Cr ▲3.7% | ₹27 Cr ▲80.0% | ₹15 Cr ▲87.5% | ₹8 Cr ▼72.4% | ₹29 Cr |
| Investing CF | ₹-266 Cr ▼18.8% | ₹-224 Cr ▲38.6% | ₹-365 Cr ▼1006.1% | ₹-33 Cr ▲72.7% | ₹-121 Cr ▼19.8% | ₹-101 Cr ▼320.8% | ₹-24 Cr ▼14.3% | ₹-21 Cr ▲16.0% | ₹-25 Cr ▼31.6% | ₹-19 Cr |
| Financing CF | ₹4 Cr ▼98.5% | ₹261 Cr ▲9.2% | ₹239 Cr ▲2091.7% | ₹-12 Cr ▼108.6% | ₹140 Cr ▲94.4% | ₹72 Cr | ₹0 Cr ▼100.0% | ₹6 Cr ▼60.0% | ₹15 Cr ▲314.3% | ₹-7 Cr |
| Net Cash Flow | ₹30 Cr ▼80.8% | ₹156 Cr ▲15700.0% | ₹-1 Cr ▼105.0% | ₹20 Cr ▲150.0% | ₹8 Cr ▲900.0% | ₹-1 Cr ▼133.3% | ₹3 Cr | ₹0 Cr ▲100.0% | ₹-2 Cr ▼166.7% | ₹3 Cr |
| Free Cash Flow | ₹-36 Cr ▲52.6% | ₹-76 Cr ▲51.0% | ₹-155 Cr ▼400.0% | ₹-31 Cr ▲32.6% | ₹-46 Cr ▲40.3% | ₹-77 Cr ▼1383.3% | ₹6 Cr ▲185.7% | ₹-7 Cr ▲56.3% | ₹-16 Cr ▼260.0% | ₹10 Cr |
Values in ₹ Cr · Source: Screener.in
Key Ratios History
| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 99d ▼5.7% | 105d ▲0.0% | 105d ▼22.8% | 136d ▲18.3% | 115d ▼10.9% | 129d ▲50.0% | 86d ▼25.9% | 116d ▲19.6% | 97d ▲16.9% | 83d |
| Inventory Days | 149d ▲25.2% | 119d ▼14.4% | 139d ▲6.1% | 131d ▼12.7% | 150d ▲22.0% | 123d ▼16.9% | 148d ▲55.8% | 95d ▲6.7% | 89d ▲17.1% | 76d |
| Days Payable | 99d ▼3.9% | 103d ▼13.4% | 119d ▼24.2% | 157d ▼0.6% | 158d ▼8.1% | 172d ▲17.8% | 146d ▼13.1% | 168d ▲9.1% | 154d ▲4.1% | 148d |
| Cash Conv. Cycle | 149d ▲23.1% | 121d ▼3.2% | 125d ▲12.6% | 111d ▲3.7% | 107d ▲33.8% | 80d ▼9.1% | 88d ▲104.7% | 43d ▲38.7% | 31d ▲181.8% | 11d |
| Working Capital Days | 116d ▼5.7% | 123d ▲53.8% | 80d ▼42.4% | 139d ▼1.4% | 141d ▲176.5% | 51d ▲50.0% | 34d ▲21.4% | 28d ▼56.3% | 64d ▲39.1% | 46d |
| ROCE | 32.0% ▲60.0% | 20.0% ▲25.0% | 16.0% ▼23.8% | 21.0% ▼12.5% | 24.0% ▼27.3% | 33.0% ▲22.2% | 27.0% ▼20.6% | 34.0% ▼10.5% | 38.0% | — |
Source: Screener.in · Lower days = better efficiency
About Acutaas Chemicals Limited
Ami Organics Limited is one of the leading research and development-driven manufacturers of specialty chemicals. The company manufactures different types of Advanced Pharmaceutical Intermediates and Active Pharmaceutical Ingredients (API) for New Chemical Entities, and materials for agrochemicals and fine chemicals.[1]
Healthcare · Pharmaceuticals & Biotechnology
Related Analysis
Frequently Asked Questions
What is Acutaas Chemicals Limited share price today?▾
Acutaas Chemicals Limited (ACUTAAS) is currently trading at ₹3,677 on NSE, up 0.57% as of the last market session. Prices update daily after market close on MarketNetra.
Is Acutaas Chemicals Limited available in F&O (Futures & Options)?▾
Yes, Acutaas Chemicals Limited (ACUTAAS) is part of the NSE F&O segment with a lot size of 1 shares. Options are available with monthly expiry contracts. You can track the full option chain and OI analysis on MarketNetra.
What is Acutaas Chemicals Limited 52-week high and low?▾
Acutaas Chemicals Limited's 52-week high is ₹3,740 and the 52-week low is ₹1,125. The current price of ₹3,677 is 1.7% below the 52W high.
What is Acutaas Chemicals Limited P/E ratio?▾
Acutaas Chemicals Limited's current P/E ratio is 83.2. This indicates the market is paying ₹83.2 for every ₹1 of earnings. Compare this to the sector average to assess relative valuation.
How to trade Acutaas Chemicals Limited options?▾
Acutaas Chemicals Limited options are traded on NSE with monthly expiry contracts (lot size: 1 shares). To trade ACUTAAS options: select your expiry on the option chain page, identify key OI strikes, check the PCR and buildup type on OI analysis, and review FII/DII flows for institutional sentiment before taking a position.